Kelly Cleary Quoted in Decision Health/Part B News on Prediction for Drug Pricing in 2021

January 4, 2021

Reading Time : 1 min

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Sarah Richmond

Senior Communications Manager

Akin Gump health care and life sciences partner Kelly Cleary has been quoted in the Decision Health/Part B News article “More 2021 predictions: Drug pricing, X modifiers, HHS chief.” Cleary shares her thoughts on the international pricing index (IPI), which, under President Trump, pegs Medicare drug payments to foreign prices and resulted in an interim final rule issued in November.

According to the article, the rule creates a dilemma for President-elect Joe Biden, as it would require him to tie Medicare reimbursement to prices for drugs outside of the United States. According to Cleary, though, the IPI could give Biden “an exit strategy” if he doesn’t want to go that route, and give him “the option to scrap the rule altogether.” She added that he could also “kick the can a little bit -- put the [IPI] in through notice and comment and keep the threat of it dangling out there, perhaps, for leverage in negotiations with industry, just to see what else they could come up with.”

Share This Insight

People Mentioned in This News

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.